Registration open for second annual Staff Professional Development Week

2022 events take place Feb. 28-March 4

University leaders will kick off Staff Professional Development Week  on Monday, Feb. 28, 2-3 p.m., with keynote speaker, Olympic gold medalist Mary Wineberg, CECH ‘02, as she encourages us all to achieve our own dreams.

full schedule of workshops will follow March 1-4, providing opportunities to learn new skills, indulge in self-care and engage in professional relationship building. You can add sessions you’re interested in directly to your calendars from the Staff Senate site

Live captioning will be provided at all sessions (requests for other accessibility related accommodations can be made by emailing hrlearning@uc.edu no later than Feb. 21).

Staff Professional Development Week is a collaboration between the Staff Success Center, Staff Senate, and Central HR as part of the Staff Enrichment Pathway. All events will be held virtually due to COVID concerns.

If you or other staff need access to computers to attend sessions, please reach out to the Staff Success Center at hrlearning@uc.edu to sign up to use one of the computer labs to attend.

Related Stories

1

Ohio nurses weigh in on proposed federal loan rule

December 12, 2025

Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.

2

UC awarded nearly $1 million to help fight infant obesity spike

December 12, 2025

University of Cincinnati researcher Cathy Stough spoke with Spectrum News1 about a nearly $1 million National Institutes of Health grant awarded to UC to help prevent infant obesity through early nutrition support and family-based interventions.

3

New combination treatment improves multiple myeloma outcomes

December 11, 2025

The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.